# Interferon Gamma in Treating Patients With Recurrent or Metastatic Melanoma or Other Solid Tumors

> **NCT00004016** · PHASE1 · COMPLETED · sponsor: **University of Rochester**

## Conditions studied

- Melanoma (Skin)
- Unspecified Adult Solid Tumor, Protocol Specific

## Interventions

- **BIOLOGICAL:** recombinant interferon gamma

## Key facts

- **NCT ID:** NCT00004016
- **Lead sponsor:** University of Rochester
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 1999-04
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** — (—)
- **Last updated:** 2013-06-06

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00004016

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00004016, "Interferon Gamma in Treating Patients With Recurrent or Metastatic Melanoma or Other Solid Tumors". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT00004016. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*